Biotech Most Active Stocks: Gilead Sciences (NASDAQ:GILD), EXACT Sciences Corporation (NASDAQ:EXAS), Endocyte (NASDAQ:ECYT), Arena Pharmaceuticals (NASDAQ:ARNA)

Gilead Sciences Inc. (NASDAQ:GILD) announced that it has elected to settle its conversion obligations in connection with any 1.00% Senior Convertible Notes due 2014 (the “Notes”) submitted for conversion on or after February 1 2014 entirely in cash. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was -4.01% in last session and finished the day at $68.55. Traded volume was 29.25million shares in the last session and … Continue reading Biotech Most Active Stocks: Gilead Sciences (NASDAQ:GILD), EXACT Sciences Corporation (NASDAQ:EXAS), Endocyte (NASDAQ:ECYT), Arena Pharmaceuticals (NASDAQ:ARNA)

Mortgage Investment: KKR Financial Holdings (NYSE:KFN), CYS Investments Inc (NYSE:CYS), Ocwen Financial (NYSE:OCN), Western Asset Mortgage Capital (NYSE:WMC)

KKR Financial Holding LLC (NYSE:KFN) presently has a stellar rank, in the top 10% of the coverage universe, which suggests it is among the top most “interesting” ideas that merit further research by investors. But making KKR Financial Holdings LLC (NYSE:KFN) an even more interesting and timely stock to look at, is the fact that in trading on Wednesday, shares of KKR Financial Holdings LLC … Continue reading Mortgage Investment: KKR Financial Holdings (NYSE:KFN), CYS Investments Inc (NYSE:CYS), Ocwen Financial (NYSE:OCN), Western Asset Mortgage Capital (NYSE:WMC)

Plug Power Inc. (NASDAQ:PLUG) the fuel-cell maker was in the news again yesterday, after CEO Andy Marsh told MarketWatch that the company had “signed an additional order in North America with a global automaker. Plug Power Inc. (NASDAQ:PLUG) stock performance was -23.94% in last session and finished the day at $6.45. Traded volume was 119.25 million shares in the last session and the average volume … Continue reading Top Losers: Plug Power Inc. (NASDAQ:PLUG), Facebook Inc. (NASDAQ:FB), Exelixis (NASDAQ:EXEL), FuelCell Energy Inc. (NASDAQ:FCEL)

Akebia Therapeutics Inc. (NASDAQ:AKBA) offered 5.9 million shares in its Thursday IPO at $17 a share, the high end of the stock’s expected price range. Among other therapeutics, the biopharma company is developing a once-daily oral therapy for patients with kidney disease. Akebia Therapeutics, Inc. (NASDAQ:AKBA) stock performance was -0.99% in last session and finished the day at $20.00. Traded volume was 219,904 million shares … Continue reading Biotech New Lows: Akebia Therapeutics (NASDAQ:AKBA), Galmed Pharmaceuticals (NASDAQ:GLMD), Tetralogic Pharmaceuticals (NASDAQ:TLOG), Dipexium Pharmaceuticals (NASDAQ:DPRX)

Facebook Inc (NASDAQ:FB) Chief Operating Officer Sheryl Sandberg said she declined in 2008 to limit the recruitment or hiring of Google Inc. (GOOG) employees after being contacted by two senior officials at the search engine company. Facebook Inc (NASDAQ:FB) stock performance was -4.67% in last session and finished the day at $64.10. Traded volume was 85,530,504 million shares in the last session and the average … Continue reading Tech Sector Most Active: Facebook Inc (NASDAQ:FB), AT&T Inc. (NYSE:T), Microsoft Corporation (NASDAQ:MSFT), Nokia Corporation (ADR) (NYSE:NOK)

Nokia Corporation (ADR) (NYSE:NOK) (BIT:NOK1V) (HEL:NOK1V) is going through some big changes right now with the sale of its devices division. Morgan Stanley analyst Francois Meunier and his team have raised their price target for the company to €6 a share from €5.20 a share but maintained their Equal-Weight rating on the stock. Nokia Corporation (ADR) (NYSE:NOK) stock performance was 0.70% in last session and … Continue reading Large Cap Active Runners: Nokia Corporation (ADR) (NYSE:NOK), Citigroup Inc (NYSE:C), Micron Technology (NASDAQ:MU), Yahoo! Inc. (NASDAQ:YHOO)